Dominique Leprince

Dominique Leprince

Auto-generated profile, based on publicly available information

Dominique Leprince

CNRS UMR 8161, Institut de Biologie de Lille, Université Lille Nord de France, Institut Pasteur de Lille, IFR 142, 1 Rue Calmette, 59017 Lille Cedex, France

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 1990 in Nature
Verified
Journal Article
Closed access
PDF file
Bohdan WasylykBohdan Wasylyk
Bohdan Wasylyk
CWC. Wasylyk
C. Wasylyk
PFP. Flores
P. Flores
ABA. Begue
A. Begue
DLD. Leprince
D. Leprince
DSD. Stehelin
D. Stehelin

1 November 1983 in Nature
Verified
Journal Article
Closed access
DLD. Leprince
D. Leprince
AGA. Gegonne
A. Gegonne
JCJ. Coll
J. Coll
CTC. de Taisne
C. de Taisne
ASA. Schneeberger
A. Schneeberger
DSD. Stehelin
D. Stehelin

30 September 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PDPhilippe Dhordain
Philippe Dhordain
OAOlivier Albagli
Olivier Albagli
RLRichard J. Lin
Richard J. Lin
SAStéphane Ansieau
Stéphane Ansieau
SQSabine Quief
Sabine Quief
DLDominique Leprince
Dominique Leprince
TheLAZ3/BCL6(lymphoma-associated zinc finger 3/B cell lymphomas 6) gene frequently is altered in non-Hodgkin lymphomas. It encodes a sequence-specific DNA binding transcriptional repressor that contains a conserved N-terminal domain, termed BTB/POZ (bric-à-brac tramtrack broad complex/pox viruses and zinc fingers). Using a yeast two-hybrid screen, we show here that the LAZ3/BCL6 BTB/POZ domain interacts with the SMRT (silencing mediator of retinoid and thyroid receptor) protein. SMRT originally was identified as a corepressor of unliganded retinoic acid and thyroid receptors and forms a repressive complex with a mammalian homolog of the yeast transcriptional repressor SIN3 and the HDAC-1 histone deacetylase. Protein binding assays demonstrate that the LAZ3/BCL6 BTB/POZ domain directly interacts with SMRTin vitro. Furthermore, DNA-bound LAZ3/BCL6 recruits SMRTin vivo, and both overexpressed proteins completely colocalize in nuclear dots. Finally, overexpression of SMRT enhances the LAZ3/BCL6-mediated repression. These results define SMRT as a corepressor of LAZ3/BCL6 and suggest that LAZ3/BCL6 and nuclear hormone receptors repress transcription through shared mechanisms involving SMRT recruitment and histone deacetylation.

1 July 1992 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
KMKay Macleod
Kay Macleod
DLDominique Leprince
Dominique Leprince
DSDominique Stehelin
Dominique Stehelin

16 January 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
QZQinghong Zhang
Qinghong Zhang
SWSu-Yan Wang
Su-Yan Wang
CFCapucine Fleuriel
Capucine Fleuriel
DLDominique Leprince
Dominique Leprince
JRJonathan V. Rocheleau
Jonathan V. Rocheleau
RGRichard H. Goodman
Richard H. Goodman
The Sir2 histone deacetylases are important for gene regulation, metabolism, and longevity. A unique feature of these enzymes is their utilization of NAD + as a cosubstrate, which has led to the suggestion that Sir2 activity reflects the cellular energy state. We show that SIRT1, a mammalian Sir2 homologue, is also controlled at the transcriptional level through a mechanism that is specific for this isoform. Treatment with the glycolytic blocker 2-deoxyglucose (2-DG) decreases association of the redox sensor CtBP with HIC1, an inhibitor of SIRT1 transcription. We propose that the reduction in transcriptional repression mediated by HIC1, due to the decrease of CtBP binding, increases SIRT1 expression. This mechanism allows the specific regulation of SIRT1 in response to nutrient deprivation.

1 April 2007 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
NSNicolas Stankovic-Valentin
Nicolas Stankovic-Valentin
SDSophie Deltour
Sophie Deltour
JSJacob Seeler
Jacob Seeler
SPSébastien Pinte
Sébastien Pinte
GVGérard Vergoten
Gérard Vergoten
DLDominique Leprince
Dominique Leprince
Tumor suppressor HIC1 (hypermethylated in cancer 1) is a gene that is essential for mammalian development, epigenetically silenced in many human tumors, and involved in a complex pathway regulating P53 tumor suppression activity. HIC1 encodes a sequence-specific transcriptional repressor containing five Krüppel-like C2H2 zinc fingers and an N-terminal BTB/POZ repression domain. Here, we show that endogenous HIC1 is SUMOylated in vivo on a phylogenetically conserved lysine, K314, located in the central region which is a second repression domain. K314R mutation does not influence HIC1 subnuclear localization but significantly reduces its transcriptional repression potential, as does the mutation of the other conserved residue in the ψKXE consensus, E316A, or the overexpression of the deSUMOylase SSP3/SENP2. Furthermore, HIC1 is acetylated in vitro by P300/CBP. Strikingly, the K314R mutant is less acetylated than wild-type HIC1, suggesting that this lysine is a target for both SUMOylation and acetylation. We further show that HIC1 transcriptional repression activity is positively controlled by two types of deacetylases, SIRT1 and HDAC4, which increase the deacetylation and SUMOylation, respectively, of K314. Knockdown of endogenous SIRT1 by the transfection of short interfering RNA causes a significant loss of HIC1 SUMOylation. Thus, this dual-deacetylase complex induces either a phosphorylation-dependent acetylation-SUMOylation switch through a ψKXEXXSP motif, as previously shown for MEF2, or a phosphorylation-independent switch through a ψKXEP motif, as shown here for HIC1, since P317A mutation severely impairs HIC1 acetylation. Finally, our results demonstrate that HIC1 is a target of the class III deacetylase SIRT1 and identify a new posttranslational modification step in the P53-HIC1-SIRT1 regulatory loop.